October 21, 2022
PAR-22-242 - Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
This Notice announces the participation of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in PAR-22-242 – “Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)”, effective immediately.
The following sections of PAR-22-242 have been modified (changes shown in bold italics) to reflect the participation of NICHD in this Funding Opportunity Announcement (FOA):
Part 1. Overview Information
Components of Participating Organizations
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Neurological Disorders and Stroke (NINDS)
Assistance Listing Number(s)
93.399, 93.393, 93.394, 93.395, 93.396, 93.853, 93.173, 93.121, 93.846, 93.867, 93.865
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
IC-Specific Interest
National Institute of Child Health and Human Development (NICHD)
NICHD’s mission is to lead research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. Within the goals of this FOA, NICHD seeks innovative research to help advance this mission. Research areas of interest include, but are not limited to novel and innovative approaches and technologies to: a) improve monitoring, detection, and prevention of infectious disease and related complications in infants, children, adolescents and pregnant people, b) accelerate safe and non-invasive assessment of human placental development and function in real time across pregnancy, c) facilitate emergency and trauma care, d) improve access to function-restoring modalities in people with physical disabilities, (e) mitigate functional impairment in children with autism and intellectual and learning disabilities or developmental delays, (f) reduce pediatric healthcare- and treatment-related distress and pain, and (g) reduce disparities in gynecologic disease and maternal and pediatric health outcomes.
Section VII. Agency Contacts
Scientific/Research Contact(s)
Toyin Ajisafe, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-9242
Email: [email protected]
Financial/Grants Management Contact(s)
Margaret Young
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-642-4552
Email: [email protected]
All other aspects of the FOA remain the same.
Toyin Ajisafe, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-9242
Email: [email protected]
and Human Services (HHS)
